186 related articles for article (PubMed ID: 35857172)
21. Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose-positron emission tomography to differentiate between benign and malignant lesions.
Watanabe M; Kato H; Katayama D; Soeda F; Matsunaga K; Watabe T; Tatsumi M; Shimosegawa E; Tomiyama N
Ann Nucl Med; 2022 Nov; 36(11):951-963. PubMed ID: 36057012
[TBL] [Abstract][Full Text] [Related]
22. Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.
Røe K; Aleksandersen TB; Kristian A; Nilsen LB; Seierstad T; Qu H; Ree AH; Olsen DR; Malinen E
Acta Oncol; 2010 Oct; 49(7):914-21. PubMed ID: 20831478
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic Analysis of Dynamic
Schwartz J; Grkovski M; Rimner A; Schöder H; Zanzonico PB; Carlin SD; Staton KD; Humm JL; Nehmeh SA
J Nucl Med; 2017 Jun; 58(6):911-919. PubMed ID: 28232611
[TBL] [Abstract][Full Text] [Related]
24. 2-Deoxy-2-[fluorine-18] fluoro-d-glucose uptake on positron emission tomography is associated with programmed death ligand-1 expression in patients with pulmonary adenocarcinoma.
Kaira K; Shimizu K; Kitahara S; Yajima T; Atsumi J; Kosaka T; Ohtaki Y; Higuchi T; Oyama T; Asao T; Mogi A
Eur J Cancer; 2018 Sep; 101():181-190. PubMed ID: 30077123
[TBL] [Abstract][Full Text] [Related]
25. Comparative Performance of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT in Detection and Characterization of Pulmonary Lesions in 121 Oncologic Patients.
Sawicki LM; Grueneisen J; Buchbender C; Schaarschmidt BM; Gomez B; Ruhlmann V; Wetter A; Umutlu L; Antoch G; Heusch P
J Nucl Med; 2016 Apr; 57(4):582-6. PubMed ID: 26742715
[TBL] [Abstract][Full Text] [Related]
26. Maximum Standardized Uptake Value on Positron Emission Tomography is Associated With More Advanced Disease and High-risk Features in Lung Adenocarcinoma.
Koike T; Sato N; Hosoda Y; Tazawa M; Goto T; Sato S; Yamazaki M; Toyabe SI; Tsuchida M
Semin Thorac Cardiovasc Surg; 2022; 34(3):1051-1060. PubMed ID: 34320398
[No Abstract] [Full Text] [Related]
27. FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer.
Thureau S; Dubray B; Modzelewski R; Bohn P; Hapdey S; Vincent S; Anger E; Gensanne D; Pirault N; Pierrick G; Vera P
Radiat Oncol; 2018 Oct; 13(1):208. PubMed ID: 30352608
[TBL] [Abstract][Full Text] [Related]
28. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR
Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033
[TBL] [Abstract][Full Text] [Related]
29. Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.
Kawakita N; Toba H; Kawakami Y; Takizawa H; Bando Y; Otuska H; Matsumoto D; Takashima M; Tsuboi M; Yoshida M; Kondo K; Tangoku A
Int J Clin Oncol; 2020 Jun; 25(6):1079-1089. PubMed ID: 32130543
[TBL] [Abstract][Full Text] [Related]
30. The imaging quantification of multiple organs by dynamic
Yao J; Liu J; Bi L; Huang Y; Wang L; Zhang F; Wang Y; Jin H
Int J Med Sci; 2022; 19(10):1539-1547. PubMed ID: 36185330
[No Abstract] [Full Text] [Related]
31. Enhanced glucose metabolism mediated by CD147 is associated with
Zhang Y; Liu J; Sun Y; Yu X; Wang J; Dai D; Zhu Y; Song X; Zhu L; Li X; Xu W
Thorac Cancer; 2020 May; 11(5):1245-1257. PubMed ID: 32162491
[TBL] [Abstract][Full Text] [Related]
32. FDG PET/CT used in identifying adult-onset Still's disease in connective tissue diseases.
Zhou X; Li Y; Wang Q
Clin Rheumatol; 2020 Sep; 39(9):2735-2742. PubMed ID: 32180040
[TBL] [Abstract][Full Text] [Related]
33. Expert consensus on oncological [
Yu H; Gu Y; Fan W; Gao Y; Wang M; Zhu X; Wu Z; Liu J; Li B; Wu H; Cheng Z; Wang S; Zhang Y; Xu B; Li S; Shi H
Eur Radiol; 2023 Jan; 33(1):615-626. PubMed ID: 35751696
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.
Tixier F; Vriens D; Cheze-Le Rest C; Hatt M; Disselhorst JA; Oyen WJ; de Geus-Oei LF; Visser EP; Visvikis D
J Nucl Med; 2016 Jul; 57(7):1033-9. PubMed ID: 26966161
[TBL] [Abstract][Full Text] [Related]
35. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
36. Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by
Xiao J; Yu H; Sui X; Hu Y; Cao Y; Liu G; Zhang Y; Hu P; Wang Y; Li C; Xu B; Shi H
Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):269-278. PubMed ID: 34185138
[TBL] [Abstract][Full Text] [Related]
37. Correlation of (18)F-FDG avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer.
Shusharina N; Cho J; Sharp GC; Choi NC
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):137-44. PubMed ID: 24725696
[TBL] [Abstract][Full Text] [Related]
38. High-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PET.
Wang Y; Abdelhafez YG; Spencer BA; Verma R; Parikh M; Stollenwerk N; Nardo L; Jones T; Badawi RD; Cherry SR; Wang G
J Nucl Med; 2024 May; 65(5):714-721. PubMed ID: 38548347
[TBL] [Abstract][Full Text] [Related]
39. Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study.
Li Y; Lin X; Li Y; Lv J; Hou P; Liu S; Chen P; Wang M; Zhou C; Wang X
Mol Imaging Biol; 2022 Apr; 24(2):309-320. PubMed ID: 34816283
[TBL] [Abstract][Full Text] [Related]
40. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
